|
SWAP70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.357800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.410210E-02 |
| Normal-vs-Stage2 |
1.222140E-02 |
| Normal-vs-Stage3 |
2.117300E-03 |
| Normal-vs-Stage4 |
5.924500E-03 |
| Stage1-vs-Stage2 |
3.692000E-01 |
| Stage1-vs-Stage3 |
1.507830E-01 |
| Stage1-vs-Stage4 |
2.079200E-01 |
| Stage2-vs-Stage3 |
8.754600E-01 |
| Stage2-vs-Stage4 |
7.900600E-01 |
| Stage3-vs-Stage4 |
8.826600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.078100E-03 |
| Normal-vs-AfricanAmerican |
3.705600E-01 |
| Normal-vs-Asian |
1.029690E-02 |
| Caucasian-vs-AfricanAmerican |
2.737600E-01 |
| Caucasian-vs-Asian |
7.288600E-01 |
| AfricanAmerican-vs-Asian |
2.285800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.369400E-04 |
| Normal-vs-Female |
8.215100E-03 |
| Male-vs-Female |
1.016040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.692400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.637800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.633300E-04 |
| Normal-vs-Age(81-100Yrs) |
5.707200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.462000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.764400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.369600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.130800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.906000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.180600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.741000E-03 |
| Classical-VS-Follicular |
9.847000E-01 |
| Classical-VS-Other |
1.081850E-01 |
| Classical-VS-Normal |
8.297000E-03 |
| Tall-VS-Follicular |
5.018000E-02 |
| Tall-VS-Other |
4.773000E-01 |
| Tall-VS-Normal |
1.979640E-04 |
| Follicular-VS-Other |
2.338400E-01 |
| Follicular-VS-Normal |
6.506000E-02 |
| Other-VS-Normal |
2.132000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.958600E-03 |
| Normal-vs-N1 |
2.197500E-03 |
| N0-vs-N1 |
4.166600E-01 |
|
|
